• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于益生菌药物剂量筛选的微流控装置的制造:乳腺癌治疗的精准医学

Fabrication of a microfluidic device for probiotic drug's dosage screening: Precision Medicine for Breast Cancer Treatment.

作者信息

Salehi Ali, Naserzadeh Parvaneh, Tarighi Parastoo, Afjeh-Dana Elham, Akhshik Masoud, Jafari Amir, Mackvandi Pooyan, Ashtari Behnaz, Mozafari Masoud

机构信息

Radiation Biology Research Centre, Iran University of Medical Sciences, Tehran, Iran; Department of Medical Nanotechnology, Faculty of Advanced Technologies in Medicine, Iran University of Medical Sciences. Tehran, Iran.

Endocrine Research Center, Institute of Endocrinology and Metabolism, Iran University of Medical Sciences, Tehran, Iran.

出版信息

Transl Oncol. 2023 Aug;34:101674. doi: 10.1016/j.tranon.2023.101674. Epub 2023 May 22.

DOI:10.1016/j.tranon.2023.101674
PMID:37224765
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10302160/
Abstract

Breast cancer is the most common cancer in women; it has been affecting the lives of millions each year globally and microfluidic devices seem to be a promising method for the future advancements in this field. This research uses a dynamic cell culture condition in a microfluidic concentration gradient device, helping us to assess breast anticancer activities of probiotic strains against MCF-7 cells. It has been shown that MCF-7 cells could grow and proliferate for at least 24 h; however, a specific concentration of probiotic supernatant could induce more cell death signaling population after 48 h. One of our key findings was that our evaluated optimum dose (7.8 mg/L) was less than the conventional static cell culture treatment dose (12 mg/L). To determine the most effective dose over time and the percentage of apoptosis versus necrosis, flowcytometric assessment was performed. Exposing the MCF-7 cells to probiotic supernatant after 6, 24 and 48 h, confirmed that the apoptotic and necrotic cell death signaling were concentration and time dependent. We have shown a case that these types of microfluidics platforms performing dynamic cell culture could be beneficial in personalized medicine and cancer therapy.

摘要

乳腺癌是女性中最常见的癌症;每年在全球范围内影响着数百万人的生活,而微流控设备似乎是该领域未来发展的一种有前景的方法。本研究在微流控浓度梯度装置中采用动态细胞培养条件,帮助我们评估益生菌菌株对MCF - 7细胞的乳腺癌抗癌活性。结果表明,MCF - 7细胞可以生长和增殖至少24小时;然而,特定浓度的益生菌上清液在48小时后可诱导更多细胞死亡信号群体。我们的一项关键发现是,我们评估的最佳剂量(7.8毫克/升)低于传统静态细胞培养治疗剂量(12毫克/升)。为了确定随时间变化的最有效剂量以及凋亡与坏死的百分比,进行了流式细胞术评估。在6小时、24小时和48小时后将MCF - 7细胞暴露于益生菌上清液,证实凋亡和坏死性细胞死亡信号是浓度和时间依赖性的。我们展示了一个案例,即这些进行动态细胞培养的微流控平台在个性化医学和癌症治疗中可能是有益的。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e52c/10302160/d71700453f23/gr8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e52c/10302160/7983ad05dafb/ga1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e52c/10302160/4c80eb2edfcc/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e52c/10302160/a28e8cea7a42/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e52c/10302160/4de156b737c2/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e52c/10302160/cedd80e52790/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e52c/10302160/5430ce53fe09/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e52c/10302160/62686e20b5c2/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e52c/10302160/4e8c0809246e/gr7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e52c/10302160/d71700453f23/gr8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e52c/10302160/7983ad05dafb/ga1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e52c/10302160/4c80eb2edfcc/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e52c/10302160/a28e8cea7a42/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e52c/10302160/4de156b737c2/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e52c/10302160/cedd80e52790/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e52c/10302160/5430ce53fe09/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e52c/10302160/62686e20b5c2/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e52c/10302160/4e8c0809246e/gr7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e52c/10302160/d71700453f23/gr8.jpg

相似文献

1
Fabrication of a microfluidic device for probiotic drug's dosage screening: Precision Medicine for Breast Cancer Treatment.用于益生菌药物剂量筛选的微流控装置的制造:乳腺癌治疗的精准医学
Transl Oncol. 2023 Aug;34:101674. doi: 10.1016/j.tranon.2023.101674. Epub 2023 May 22.
2
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
3
An integrated microfluidic cell array for apoptosis and proliferation analysis induction of breast cancer cells.用于乳腺癌细胞凋亡和增殖分析诱导的集成微流控细胞阵列。
Biomicrofluidics. 2010 Oct 8;4(4):44104. doi: 10.1063/1.3497376.
4
Three-gradient constructions in a flow-rate insensitive microfluidic system for drug screening towards personalized treatment.用于针对个体化治疗进行药物筛选的流速不敏感微流控系统中的三梯度结构。
Talanta. 2020 Feb 1;208:120477. doi: 10.1016/j.talanta.2019.120477. Epub 2019 Oct 18.
5
An Integrated Microfluidics Approach for Personalized Cancer Drug Sensitivity and Resistance Assay.一种用于个性化癌症药物敏感性和耐药性检测的集成微流控方法。
Adv Biosyst. 2019 Nov;3(11):e1900001. doi: 10.1002/adbi.201900001. Epub 2019 May 20.
6
Anticancer Properties of Probiotic Saccharomyces boulardii Supernatant on Human Breast Cancer Cells.益生菌布拉氏酵母上清液对人乳腺癌细胞的抗癌特性。
Probiotics Antimicrob Proteins. 2022 Dec;14(6):1130-1138. doi: 10.1007/s12602-021-09756-w. Epub 2022 Jan 30.
7
Low cost microfluidic cell culture array using normally closed valves for cytotoxicity assay.使用常闭阀的低成本微流控细胞培养阵列用于细胞毒性测定。
Talanta. 2014 Nov;129:491-8. doi: 10.1016/j.talanta.2014.06.020. Epub 2014 Jun 18.
8
High-Throughput Screening of Anti-cancer Drugs Using a Microfluidic Spheroid Culture Device with a Concentration Gradient Generator.使用带有浓度梯度发生器的微流控球体培养装置进行抗癌药物的高通量筛选
Curr Protoc. 2022 Sep;2(9):e529. doi: 10.1002/cpz1.529.
9
Microfluidic Arrays of Breast Tumor Spheroids for Drug Screening and Personalized Cancer Therapies.用于药物筛选和个体化癌症治疗的乳腺癌球体微流控阵列。
Adv Healthc Mater. 2022 Jan;11(1):e2101085. doi: 10.1002/adhm.202101085. Epub 2021 Oct 24.
10
A modular, reversible sealing, and reusable microfluidic device for drug screening.一种用于药物筛选的模块化、可逆密封和可重复使用的微流控装置。
Anal Chim Acta. 2021 Nov 15;1185:339068. doi: 10.1016/j.aca.2021.339068. Epub 2021 Sep 17.

引用本文的文献

1
Tumor-on-chip platforms for breast cancer continuum concept modeling.用于乳腺癌连续体概念建模的芯片肿瘤平台。
Front Bioeng Biotechnol. 2024 Oct 2;12:1436393. doi: 10.3389/fbioe.2024.1436393. eCollection 2024.
2
Editorial Note: Biomaterials in Cancer - From Research Breakthroughs to Clinical Implementation.编者按:癌症中的生物材料——从研究突破到临床应用。
Transl Oncol. 2024 Oct;48:102061. doi: 10.1016/j.tranon.2024.102061. Epub 2024 Jul 26.

本文引用的文献

1
Effect of a Nanostructured Titanium Surface on Gingival Cell Adhesion, Viability and Properties against .纳米结构钛表面对牙龈细胞黏附、活力及抗……性能的影响
Materials (Basel). 2021 Dec 13;14(24):7686. doi: 10.3390/ma14247686.
2
Drug Targeting of Inflammatory Bowel Diseases by Biomolecules.生物分子对炎症性肠病的药物靶向治疗
Nanomaterials (Basel). 2021 Aug 10;11(8):2035. doi: 10.3390/nano11082035.
3
Magnetic nanostructured lipid carrier for dual triggered curcumin delivery: Preparation, characterization and toxicity evaluation on isolated rat liver mitochondria.
磁性纳米结构脂质载体用于双重触发姜黄素递药:分离大鼠肝线粒体的制备、表征和毒性评价。
J Biomater Appl. 2022 Jan;36(6):1055-1063. doi: 10.1177/08853282211034625. Epub 2021 Jul 26.
4
Microfluidic systems to study tissue barriers to immunotherapy.微流控系统在研究组织屏障对免疫疗法的影响。
Drug Deliv Transl Res. 2021 Dec;11(6):2414-2429. doi: 10.1007/s13346-021-01016-2. Epub 2021 Jul 3.
5
Clozapine attenuates mitochondrial dysfunction, inflammatory gene expression, and behavioral abnormalities in an animal model of schizophrenia.氯氮平可减轻精神分裂症动物模型中的线粒体功能障碍、炎症基因表达及行为异常。
Neuropharmacology. 2021 Apr 1;187:108503. doi: 10.1016/j.neuropharm.2021.108503. Epub 2021 Feb 23.
6
SAHA Improves Depressive Symptoms, Cognitive Impairment and Oxidative Stress: Rise of a New Antidepressant Class.SAHA 改善抑郁症状、认知障碍和氧化应激:新型抗抑郁药类的崛起。
Neurochem Res. 2021 May;46(5):1252-1263. doi: 10.1007/s11064-021-03263-8. Epub 2021 Feb 12.
7
In Vitro Systematic Drug Testing Reveals Carboplatin, Paclitaxel, and Alpelisib as a Potential Novel Combination Treatment for Adult Granulosa Cell Tumors.体外系统药物测试表明,卡铂、紫杉醇和阿培利司是治疗成人颗粒细胞瘤的一种潜在新型联合疗法。
Cancers (Basel). 2021 Jan 20;13(3):368. doi: 10.3390/cancers13030368.
8
Diagnosis of breast cancer based on modern mammography using hybrid transfer learning.基于混合迁移学习的现代乳腺钼靶摄影术诊断乳腺癌
Multidimens Syst Signal Process. 2021;32(2):747-765. doi: 10.1007/s11045-020-00756-7. Epub 2021 Jan 11.
9
High-throughput mechanobiology: Force modulation of ensemble biochemical and cell-based assays.高通量力学生物学:基于集合物理化学和细胞的分析的力调节。
Biophys J. 2021 Feb 16;120(4):631-641. doi: 10.1016/j.bpj.2020.12.024. Epub 2021 Jan 14.
10
Breast tumor-on-chip models: From disease modeling to personalized drug screening.乳腺肿瘤芯片模型:从疾病建模到个性化药物筛选。
J Control Release. 2021 Mar 10;331:103-120. doi: 10.1016/j.jconrel.2020.12.057. Epub 2021 Jan 6.